One bottling plant and the future of manufacturing in Myanmar
Visiting a bottling plant in Myanmar last week, the impression I got was certainly not of a country that got its freedom from military rule only two years ago. The staff and management seemed motivated, efficient and committed. During the visit, though, as well as hearing about the opportunities for a country on the cusp of profound change, we also heard about the challenges of doing business there.
Ms Anu Acharya is the co-founder and CEO of Mapmygenome, a company that pioneered the field of personalised, preventive healthcare by making personal genomics tools available to the masses. With a vision to “Touch 100 million lives”, Mapmygenome was established in 2013, heralding the advent of improved healthcare through genomics-based personalised, precision medicine starting with India and other neglected populations.
Under her leadership, the company has been achieving several milestones, awards and honours. From the ET startup Awards to NASSCOM Emerge 50, WSJ’s Top global startups’ award, Red Herring Asia and Global to the recently conferred Pride of Telangana award; Mapmygenome has certainly become a force to be reckoned with.
A fiercely respected entrepreneur, she also serves as a governing board member and/or mentor for various high profile institutions such as the NIBMG, NIAB, IIITHyderabad, IvyCap Ventures, CSIR and ABLE. She is also a distinguished alumna from IIT Kharagpur.
One bottling plant and the future of manufacturing in Myanmar
Janampatri to Genomepatri - Anu Acharya 